Insider Title Company Date Price Return Shares Value
Booth Andrew Chief Financial Officer AbCellera Biologics Inc. (ABCL) 2026-02-27 $3.42 0.0% 42,600 $145,692
Booth Andrew Chief Financial Officer AbCellera Biologics Inc. (ABCL) 2023-05-26 $6.85 -64.5% 14,500 $99,325
Booth Andrew Chief Financial Officer AbCellera Biologics Inc. (ABCL) 2022-05-12 $5.79 -58.0% 85,000 $492,150
Booth Andrew Chief Financial Officer AbCellera Biologics Inc. (ABCL) 2021-11-11 $14.71 -83.5% 67,500 $993,130
Return Profit / (loss) Cost
Total -68.1% $-1,178,795 $1,730,297